(Date:10/13/2008)...- Thomson Reuters announced,today that St. Peter,s...d,its core measures processes -- such as increasin...ailure patients from 85.4 percent in first-quarter...Peter,s Hospital, part of St. Peter,s Health Care ... the nation named for eight years as,a Thomson Reu...
(Date:10/13/2008)... Management Company, Inc. (IPM) today announced it...Top Small Workplace” by The Wall Street Jour...n today’s Wall Street Journal ( www.wsj.com/...nd consulting services to a broad range of industr...e, healthcare, and consumer and industrial product...
(Date:10/13/2008)... associated with overall breast cancer risk, accor...ves of Internal Medicine , one of the JAMA/Archiv...ncreased risk for women with benign breast disease...or larger than 2 centimeters. , Caffeine is prob...esent in coffee, tea, chocolate and some medicatio...
(Date:10/13/2008)...n in people with diabetes than in those without th...sue of Archives of Ophthalmology , one of the JA...lion Americans had diagnosed diabetes mellitus in ...tes, according to background information in the ar...als with diagnosed diabetes will increase to 48.3 ...
Breaking Medicine News(10 mins):Health News:St. Peter's Hospital of Albany Improves Core Measures Processes 2Health News:St. Peter's Hospital of Albany Improves Core Measures Processes 3Health News: Integrated Project Management Named a "Top Small Workplace" by The Wall Street Journal and Winning Workplaces 2Health News: Integrated Project Management Named a "Top Small Workplace" by The Wall Street Journal and Winning Workplaces 3Health News:Study examines association between caffeine consumption and breast cancer risk 2Health News:Vision loss more common in people with diabetes 2...han others- This could be due to the presence of a...pean Molecular Biology Laboratory [EMBL], the Ger...he University of Cincinnati report in the current ...e molecular link between spontaneous physical acti...
...d a mechanism to prevent a potentially fatal heart...zanne Ooi, a postdoctoral researcher in the Facult...ession of cardiac hypertrophy can be halted by inc...ccurring proteins. This is a significant discovery...
...by bird flu, have found preliminary evidence which...ction, an official warned Wednesday . The head of...ol, Bayu Krisnamurthi, also told reporters the hum...ear to May to 86.4 percent, as compared with 74.5 ...
...ime Minister Manmohan Singh will convene a special... to discuss disease control and public health . At...on of the National Rural Health Mission (NRHM), he...uate attention to healthcare issues and ensure eff...
Other Medicine News:Health News:Molecular Basis of Obesity-Revealing the Unknown Facts 2Health News:Breakthrough for Treatment of Fatal Heart Condition 2(Date:10/13/2008)...KINTON, Mass., Oct. 13 /- Facet Solut...th follow-up on 20 patients from its US,IDE Pilot ...y Disability,Index (ODI) scores, and an 80% reduct...leg pain. Geoff Pardo, President & CEO for Facet S...arly results, which thus far not,only demonstrate ...
(Date:10/10/2008)...HINGTON and MENLO PARK, Calif., Oct. 10 /PRNewswir... announced that it plans to present,long-term foll...trials next,week at the Cardiovascular Research Fo...rdiovascular Therapeutics (TCT) meeting in Washing...e studies designed to investigate,the safety and e...
(Date:10/10/2008)...ICK, Mass., Oct. 10 /- Bost...unced the schedule of the Company,s major,events a...rch Foundation,s,(CRF) twentieth annual Transcathe...ymposium, which runs from October 12 to 17 in Wash...g a wide range of safety and,efficacy data on its ...
(Date:10/9/2008)...ny Prepares for Increased Sales and Marketing Effo...of MitraClip(R) System, MENLO PARK, Calif., Oct. ...development of devices for the percutaneous repair...keting executive team with the appointment of,Sean...s and marketing and,Chris Richardson, as vice pres...
Breaking Medicine Technology:XTENT Announces Clinical Trial Data to be Presented at Annual Meeting of Transcatheter Cardiovascular Therapeutics Next Week 2Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 2Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 3Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 4Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 5Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 6Evalve Expands Executive Leadership Team 2Evalve Expands Executive Leadership Team 3Slowed Brain Activity in Frequent Mobile Phone Users 989 1Slowed Brain Activity in Frequent Mobile Phone Users 989 2LOreal Paris Celebrates Ten Years of Hope and Healing 986 1LOreal Paris Celebrates Ten Years of Hope and Healing 986 2LOreal Paris Celebrates Ten Years of Hope and Healing 986 3LOreal Paris Celebrates Ten Years of Hope and Healing 986 4LOreal Paris Celebrates Ten Years of Hope and Healing 986 5The Pittsburgh Life Sciences Greenhouse Adds to Its Investment Portfolio 501 1The Pittsburgh Life Sciences Greenhouse Adds to Its Investment Portfolio 501 2The Pittsburgh Life Sciences Greenhouse Adds to Its Investment Portfolio 501 3The Pittsburgh Life Sciences Greenhouse Adds to Its Investment Portfolio 501 4Access Highlighted in Recent BusinessWeek Article 498 1Access Highlighted in Recent BusinessWeek Article 498 2...06, 2007 /PRNewswire-FirstCall/ --,Replidyne, Inc....I,clinical trial using faropenem medoxomil (farope... (AOM), a common infection of the,middle ear. Init...,its primary objective to show that faropenem was ... ear and to permit the dose,selection for Phase II...
...howed Complete Response or Reduction of,Lesion Siz...ch 05, 2007 /PRNewswire-FirstCall/ - Nventa,Biopha...ntation of,positive results from a clinical trial ... HspE7, an investigational therapeutic,vaccine for...omen,with the highest grade of cervical dysplasia ...
Other Medicine Technology:Replidyne Phase II Pediatric Trial Meets Primary Objective 2Replidyne Phase II Pediatric Trial Meets Primary Objective 3Nventa Announces Presentation of Positive HspE7 Data from,NCI-Sponsored Clinical Trial in Cervical Dysplasia 2Nventa Announces Presentation of Positive HspE7 Data from,NCI-Sponsored Clinical Trial in Cervical Dysplasia 3Nventa Announces Presentation of Positive HspE7 Data from,NCI-Sponsored Clinical Trial in Cervical Dysplasia 4Nventa Announces Presentation of Positive HspE7 Data from,NCI-Sponsored Clinical Trial in Cervical Dysplasia 5Nventa Announces Presentation of Positive HspE7 Data from,NCI-Sponsored Clinical Trial in Cervical Dysplasia 6The VISUCAM non-mydriatic fundus camera increases the quality and simplicity of fundus imaging. Compact, yet big enough to set the standard in ophthalmic photography, it features a unique combination
The Afinion HbA1c test and the fully automated Afinion Analyzer, give you reliable facts conveniently available when and where you need them. Advising the patient can be carried out with confidence.
An aid for advancing a pacemaker lead through the subcutaneous tissue of the chest wall to the pacemaker pocket.
The ARK-730A initiates automatic measurement at the optimum measurement point. The ARK-730A maintains fogging throughout multiple measurements, saving total examination time.
Medicine Products: